Unexplained Arterial Thrombosis: Approach to Diagnosis and Treatment
Date: July 20, 2022 Presenters: Jori May, MD; Arthur L. Allen, PharmD, CACP; Deborah Siegal MD, MSc, FRCPC; Andrea Van Beek, RN, DNP, AGPCNP-BC For more information, visit our webinar archive: https://acforum.org/web/education-web... ____________________________________ The Anticoagulation Forum (AC Forum) is a nonprofit, multidisciplinary organization dedicated to improving the quality and safety of care for patients taking antithrombotic medications. With over 15,000 members across 100+ countries, AC Forum provides: • Evidence-based clinical guidance • Rapid Resources and literature updates • Continuing education programs • National conferences and Boot Camps • Anticoagulation Stewardship leadership initiatives Learn more: https://acforum.org Resources & education: https://acforum.org/web/resource-cent... Join free membership: https://acforum.org Interested in deeper learning? • On-Demand Boot Camp: https://acforum.org/web/event-on-dema... • CARE-AF/VTE International Learning Series: https://acforum.org/web/event-care.php • Anticoagulation Center of Excellence (ACE) Program: https://acforum.org/web/ace.php #Anticoagulation #Thrombosis #DOAC #AntithromboticStewardship #AnticoagulationStewardship #ACForum
Anticoagulant Treatment of Cerebral Venous Thrombosis – Where are we in 2022?
From Anticoagulation to Intervention: Applying the 2026 Guidelines for Acute Pulmonary Embolism
Peripheral Arterial Disease: A Review and Updates | Katherin Leckie, MD, MS
ISTH Academy Presentation: Arterial Thrombosis, Pathogenesis, Epidemiology
Michigan Cardiac Rehab Network (MiCR) Telehealth Forum - April 17, 2026
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
An Approach to Hemostasis and Thrombosis for the Internist
Subclinical Atrial Fibrillation: Connecting Evidence to Practice
Apixaban vs. Rivaroxaban in Acute VTE: Uncoiling COBRRA and Its Clinical Implications
2026 Stroke Guidelines in Action
Dr. Gillian Hanley | Summer Scholar Series 2026
Venous Thromboembolism (DVT, PE) | Clinical Medicine
Emerging Evidence: Long-term oral anticoagulation following provoked VTE? Focus on the HI-PRO Trial
Scott Sherman "An Opt-Out vs Opt-In Approach for Smoking Cessation Treatment" | TOPS 126 | 6/12/26
Clotting (Thrombotic) Disorders
Anticoagulation for AF, VTE and PVT in Cirrhosis
CIMT Expert: This Test Predicts 98% of Heart Attacks
Update on the Management of Atrial Fibrillation:Focus on the New Guidelines
Recognizing Pediatric Hereditary Hematologic Malignancies (June 2026)
